功能性物质的微凝传递系统用于精密营养
1College of Food and Bioengineering, Henan University of Science and Technology, Luoyang, Henan, P.R. China.
Advances in food and nutrition research
|September 1, 2024
概括
微凝是一种多功能输送系统,可提供功能性食品物质的增强封装和有针对性的释放. 这些生物聚合物网络显示出精密营养和介入慢性疾病的前景.
科学领域:
- 食品科学与技术 食品科学与技术
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 微凝是由交联的生物聚合物形成3D网络的体粒子.
- 它们具有分散性,膨胀性,稳定性,小尺寸和高表面积等特性.
- 这些特性使它们适合封装和输送功能性物质.
研究的目的:
- 审查食品级微凝制备方法和墙壁材料.
- 总结微凝特征作为一个输送系统.
- 讨论精准营养和慢性疾病干预中的应用.
主要方法:
- 对食品级微凝的常见墙壁材料的审查.
- 分析微凝制备的原理,方法,优点和缺点.
- 微凝特性概述:可变形性,封装效率,刺激响应释放和目标传递.
主要成果:
- 微凝为功能性物质提供有效的封装和保护.
- 突出强调了刺激响应释放和有针对性的交付能力.
- 确定了精准营养和慢性疾病管理的潜在益处.
结论:
- 微凝输送系统对于功能性物质干预在精密营养中至关重要.
- 进一步设计先进的准微凝系统可以优化健康益处.
- 这项技术支持个性化的营养策略,以改善健康结果.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...


